Molecular Docking Studies of Berberine Derivative as Novel Multitarget PCSK9 and HMGCR Inhibitors. Science Essence Journal, [S. l.], v. 37, n. 1, p. 124–142, 2021. Disponível em: https://ejournals.swu.ac.th/sej/article/view/13502. Acesso em: 23 oct. 2026.